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Abstract
The cyclooctadepsipeptide emodepside and its parent compound PF1022A are broad-spectrum nematicidal drugs which
are able to eliminate nematodes resistant to other anthelmintics. The mode of action of cyclooctadepsipeptides is only
partially understood, but involves the latrophilin Lat-1 receptor and the voltage- and calcium-activated potassium channel
Slo-1. Genetic evidence suggests that emodepside exerts its anthelmintic activity predominantly through Slo-1. Indeed, slo-1
deficient Caenorhabditis elegans strains are completely emodepside resistant. However, direct effects of emodepside on Slo-
1 have not been reported and these channels have only been characterized for C. elegans and related Strongylida. Molecular
and bioinformatic analyses identified full-length Slo-1 cDNAs of Ascaris suum, Parascaris equorum, Toxocara canis, Dirofilaria
immitis, Brugia malayi, Onchocerca gutturosa and Strongyloides ratti. Two paralogs were identified in the trichocephalids
Trichuris muris, Trichuris suis and Trichinella spiralis. Several splice variants encoding truncated channels were identified in
Trichuris spp. Slo-1 channels of trichocephalids form a monophyletic group, showing that duplication occurred after the
divergence of Enoplea and Chromadorea. To explore the function of a representative protein, C. elegans Slo-1a was
expressed in Xenopus laevis oocytes and studied in electrophysiological (voltage-clamp) experiments. Incubation of oocytes
with 1-10 mM emodepside caused significantly increased currents over a wide range of step potentials in the absence of
experimentally increased intracellular Ca2+, suggesting that emodepside directly opens C. elegans Slo-1a. Emodepside wash-
out did not reverse the effect and the Slo-1 inhibitor verruculogen was only effective when applied before, but not after,
emodepside. The identification of several splice variants and paralogs in some parasitic nematodes suggests that there are
substantial differences in channel properties among species. Most importantly, this study showed for the first time that
emodepside directly opens a Slo-1 channel, significantly improving the understanding of the mode of action of this drug
class.
Citation: Kulke D, von Samson-Himmelstjerna G, Miltsch SM, Wolstenholme AJ, Jex AR, et al. (2014) Characterization of the Ca2+-Gated and Voltage-Dependent
K+-Channel Slo-1 of Nematodes and Its Interaction with Emodepside. PLoS Negl Trop Dis 8(12): e3401. doi:10.1371/journal.pntd.0003401
Editor: David L. Williams, Rush University Medical Center, United States of America
Received April 28, 2014; Accepted November 7, 2014; Published December 18, 2014
Copyright:  2014 Kulke et al. This is an open-access article distributed under the terms of the Creative Commons Attribution License, which permits
unrestricted use, distribution, and reproduction in any medium, provided the original author and source are credited.
Data Availability: The authors confirm that all data underlying the findings are fully available without restriction. All relevant data are within the paper and its
Supporting Information files.
Funding: The present study was performed as a collaborative Research project between Bayer HealthCare and the Institute of Parasitology and Tropical
Veterinary Medicine, Freie Universita¨t Berlin. Accordingly, the Institute of Parasitology and Tropical Veterinary Medicine, Freie Universita¨t Berlin received a Project
specific research grant from Bayer HealthCare AG. The funders, except for AH and DK, had no role in study design, data collection and analysis, decision to publish,
or preparation of the manuscript.
Competing Interests: DK, PhD student of the Institute of Parasitology and Tropical Veterinary Medicine, Freie Universita¨t Berlin, is employed by Bayer
HealthCare, Global Drug Discovery, Animal Health, developing veterinary pharmaceuticals including dewormers. Furthermore, AH was an employee of Bayer
HealthCare when part of the study was conducted. Except of AH and DK, Bayer HealthCare was not involved in study design, data collection, data analysis or
preparation of the manuscript. The decision to publish the manuscript was jointly taken. This does not alter our adherence to all PLOS policies on sharing data
and materials.
* Email: juergen.kruecken@fu-berlin.de
Introduction
In Ecdysozoa, large conductance potassium channels (also BK
or Maxi-K channels) are encoded by slo-1 genes [1]. Due to their
large conductance in the open state, typically exceeding 200 pS,
Slo-1 channels are of major importance for repolarization of
excitable cells. These channels are tetramers and, in almost every
animal species, all subunits are encoded by a single gene – with
teleost fish as the only known exception, encoding multiple slo-1
paralogs resulting from whole genome duplications [2]. The
opening of Slo-1 channels is controlled by the membrane potential
and intracellular free Ca2+-concentrations [Ca2+]i. Depolarization
of the membrane as well as very high transient local Ca2+
concentrations are required to open Slo-1 channels [3]. Most other
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ion channels produce subtypes with altered physiological proper-
ties through a combination of different subunits as recently
reviewed for acetylcholine and glutamate receptors [4,5]. In
contrast, several different slo-1 splice variants have been described,
e.g. for C. elegans, D. melanogaster, mice and humans, and
differential splicing is known to affect channel properties [6–9]. In
addition, the use of different tissue-specific promoters has been
described for D. melanogaster [10,11]. Indeed, the number of
different splice variants has dramatically increased during evolu-
tion, which is demonstrated by the fact that the human slo-1
ortholog kcnma1 encodes 13 alternative exons [12]. In fact, the
number of splice variants in Mammalia and Diptera is so high that
systematic analysis of the effects of the channel variants generated
by alternative splicing on voltage- and Ca2+-sensitivity has only
been performed for a few of them. The complexity of Slo-1
channel heterogeneity is further increased by the ability to form
heterotetramers [13] containing different splice variants and the
fact that channel responses to depolarization and Ca2+ are
modulated by posttranslational modifications such as palmitoyla-
tion and phosphorylation at several distinct sites [14–16].
Splice variants in C. elegans are more clearly arranged, with
four different splice sites giving rise to 12 well characterized splice
variants [17] plus three additional variants annotated in
WormBase (Slo-1a-Slo-1m, Slo-1y, Slo-1z). Expression levels of
these variants in whole C. elegans as well as voltage- and Ca2+-
sensitivity profiles of different homomeric tetramers have been
reported recently [6,17].
Nematode Slo-1 channels have received particular attention in
recent years due to their central involvement in the mode of action
of the broad-spectrum nematicidal cyclooctadepsipeptide emodep-
side [18]. C. elegans strains with slo-1 loss-of-function mutations
are completely resistant to emodepside [19]. Emodepside sensi-
tivity can be rescued by re-introducing Slo-1 from either C.
elegans or the parasitic nematodes Ancylostoma caninum and
Cooperia oncophora, but only partially by the human ortholog
KCNMA1 [19–21]. These results can be explained by either a
direct and specific interaction of emodepside with nematode Slo-1
channels or a necessary function of Slo-1 in a signal transduction
pathway downstream of an emodepside target. Ectopic expression
of Slo-1a in the pharynx muscle, which does normally not express
Slo-1 channels, in a slo-1 deficient genetic background conferred
emodepside sensitivity to pharyngeal pumping [21], suggesting
that this channel is either the direct target of the drug or that an
unidentified target is present in pharyngeal muscle cells that is
activated upstream of Slo-1. Although Slo-1 channels are widely
considered to be the most likely receptors for emodepside in
nematodes [18,22–24], direct interaction of the channel with
emodepside or its activation by this drug have not been reported.
This is in contrast to another putative emodepside target, the G
protein-coupled receptor Lat-1, an ortholog of mammalian
latrophilin receptors. Binding of the drug to its target and
activation of Lat-1 by PF1022A and emodepside have been
demonstrated [25]. However, lat-1 loss-of-function mutations in
C. elegans cause only partial emodepside resistance; the effects of
emodepside on the pharynx but not on the body muscle were
impaired [26–28].
Knowing the mode of action of new drugs has important
advantages for the prediction of efficacy in new target species [29]
and can exclude potential receptor-dependent deleterious side
effects in host species [30]. Interpretation of structure-activity
relationships are also facilitated if the receptor is known. Despite
their relatively uniform body shape, nematodes are genetically and
physiologically extremely diverse [31,32]. The cyclooctadepsipep-
tides have a very broad anthelmintic spectrum against parasitic
nematodes [18] representing all major clades [33], including
strongylids (clade V), Strongyloides (clade IV), Ascaridoidea and
Filarioidea (clade III) as well as the trichocephalids Trichuris and
Trichinella (clade I) [18]. This broad spectrum nematicidal activity
is in marked contrast to other anthelmintics that have been
developed in the last decade including tribendimidine (poor
efficacy against Strongyloides stercoralis and Trichuris trichiura
[34]), monepantel (only limited efficacy against human hook-
worms and poor or no efficacy against parasites not belonging to
clade V [35]) as well as derquantel (efficacy .95% against L4 and
adults of Trichostrongylus and Nematodirus spp. as well as against
adult H. contortus but suboptimal efficacies against L4 and adults
of Teladorsagia circumcincta, L4 of H. contortus, and some large
intestinal nematodes [36]).
For S. ratti lack of monepantel efficacy is presumably due to the
fact that no member the DEG-3/DES-2 subfamily of acetylcholine
receptors, which are the known targets of this drug, are encoded in
its genome [29]. Therefore, differences in susceptibility to
anthelmintics among nematodes can in part be explained by
presence of drug targets encoded in their genomes.
slo-1 genes and gene products have thus far only been
investigated in clade V of the phylum Nematoda [33]. Since
parasitic nematodes of vertebrates are found in four of five clades
[33] and Slo-1 is apparently a validated drug target, the present
study aimed to analyze the diversity of Slo-1 channels within the
phylum Nematoda. In addition, effects of emodepside on C.
elegans Slo-1a channel opening were determined.
Materials and Methods
Ethical statement
All animal experiments were approved by the local administra-
tions in charge and were in accordance with local laws regarding
animal welfare (Animal Welfare Act in the United States and the
‘‘Tierschutzgesetze’’ in Germany and in Switzerland as well as in
accordance with the European Union directive 2010/63/EU).
Author summary
Emodepside is an anthelmintic introduced into the market
as an ingredient of different dewormers for cats and dogs,
and is the only member of the cyclooctadepsipeptide class
which has been commercialized. The voltage-gated and
calcium-activated potassium channel Slo-1 has been
implicated in the mode of action of emodepside, but
evidence for direct emodepside-induced changes on the
properties of Slo-1 channels has not been reported.
Emodepside is active against a broad spectrum of parasitic
nematodes, but the putative target Slo-1 has only been
described for the model nematode Caenorhabditis elegans,
and for relatively closely related strongylids. Here, Slo-1
channels of ascarids, filariae and trichocephalids are
described. Unexpectedly, in the latter group two distinct
Slo-1 channels are encoded in their genomes. The C.
elegans Slo-1a channel was expressed in Xenopus laevis
oocytes. After membrane depolarization without experi-
mentally increasing intracellular Ca2+, no Slo-1 specific
currents were observed. In contrast, very large Slo-1-
specific currents were observed after preincubation of
oocytes with emodepside, suggesting that the drug opens
the C. elegans Slo-1a channel irreversibly. This is the first
report demonstrating direct interaction of a cyclooctadep-
sipeptide with a Slo-1 channel, which substantially
enhances our understanding of the mode of action of
this drug class.
Characterization of Nematode Slo-1
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Adult T. muris were obtained during controlled drug trials
performed for other studies at Bayer HealthCare AG, Global
Drug Discovery Animal Health in Monheim, Germany (approved
by Landesamt fu¨r Natur-, Umwelt- und Verbraucherschutz
Nordrhein-Westfalen (LANUV) in Recklinghausen (Germany)
under No. 200/V14) [37] and at the Swiss Tropical and Public
Health Institute in Basel, Switzerland (approved by the local
veterinary office Basel-Stadt (Switzerland) based on Swiss cantonal
and national regulations under permission no. 2070) [38]. Adult
Parascaris equorum were collected in a controlled drug trial study
conducted by von Samson-Himmelstjerna et al. that was approved
by the Landesamt fu¨r Verbraucherschutz und Lebensmittelsicher-
heit (LAVES) in Hannover (Germany) under the reference number
33.9-42502-05-07A499. Ascaris suum were obtained from a
German slaughterhouse. Dirofilaria immitis macrofilariae were
collected during routine necropsy of a naturally infected, moribund
stray dog which was euthanized due to medical reasons (Athens,
GA, USA). No information regarding owners or the history of the
dog is available. Macrofilariae of Onchocerca gutturosa were
dissected from the nuchal ligament connective tissues, obtained
from cattle post-slaughter in Banjul, Gambia, (facilitated by the
International Trypanotolerance Centre, Gambia). Consent of the
owners of the carcasses was obtained. Brugia malayi microfilariae
were provided by the NIAID/NIH Filariasis Research Reagent
Resource center (FR3). Toxocara canis RNA was obtained from a
previously published study [39].
RNA isolation and cDNA synthesis
Nematodes were homogenized on ice in Trizol (Invitrogen) or
TriFast (Peqlab) reagent using a TissueRuptor and transparent
disposable probes (Qiagen). RNA was isolated according to the
manufacturer’s instructions, except that the volume of Trizol was
increased to 5 ml per 100 mg wet tissue weight. Volumes of all
subsequently used reagents were adjusted accordingly. RNAs were
precipitated twice in the presence of glycogen (Thermo Fisher
Scientific), dissolved in water and stored at -80uC until use.
For cDNA synthesis, 1 mg total RNA was mixed with 100 pmol
of either random hexamer primers (for PCR with degenerate
primers) or oligo dT primers (for full-length PCRs; both primers
from Thermo Fisher Scientific), incubated at 65uC for 5 min and
then chilled on ice. Reverse transcription was performed in 20 ml
using 200 U Maxima Reverse Transcriptase (Thermo Fisher
Scientific), 1 mM dNTPs and 20 U RiboLock RNase inhibitor
(Thermo Fisher Scientific) by incubation at 42 uC for 30 min and
60 uC for 30 min. Finally, the enzyme was inactivated at 70 uC for
5 min. Alternatively, 200 U RevertAidM-MuLV reverse tran-
scriptase (Thermo Fisher Scientific) were used with 20 U
RiboLock RNase inhibitor, 0.5 mM dNTPs and 25 mM oligo-
dT primers.
Amplification of full-length cDNAs
Partial genomic data from T. muris and T. canis and a deduced
full-length sequence of S. ratti (for phylogenetic analysis only) were
provided by the Parasite Genomics group at the Wellcome Trust
Sanger Institute and can be obtained from http://www.sanger.ac.
uk/research/projects/parasitegenomics/.
Based on comparisons among available slo-1 cDNA sequences
of H. contortus, C. oncophora and C. elegans, degenerate primers
were designed and used to amplify and sequence small slo-1
fragments of P. equorum and A. suum. A 126 bp long cDNA T.
canis slo-1 sequence published on nematode.net [40] was
identified by BLAST. Specific primers for nested 5’- and 3’-
RACE PCR were designed using these sequence data (S1 Table).
PCRs contained 0.3 mM dNTPs, 0.4 mM of the gene-specific and
the universal primer, 1 ml cDNA and 0.5 ml Advantage 2
Polymerase Mix (Clontech) in 25 ml 16Advantage buffer. For 5’-
RACE multiple nested RACE PCRs were performed to proceed
stepwise to the 5’-end of the cDNA. Full-length sequences were
amplified using two gene-specific primers and the same PCR
protocol. PCR fragments were gel purified, cloned into pCR4
TOPO (Invitrogen) and sent to GATC Biotech for sequencing.
Primers for all full-length amplifications are provided in S1 Table.
For other nematodes, primers derived from partial slo-1
sequences identified in the T. muris, D. immitis, Onchocerca
volvulus and B. malayi genome projects were used. Using these
sequences, primers for 5’ and 3’ RACE PCR were designed and
RACE PCRs were carried out with the 5’/3’ RACE Kit, second
generation (Roche Diagnostics) as detailed previously [39]. PCRs
were performed in 25 ml 16Phusion II buffer containing 1 U
Phusion II DNA polymerase (Thermo Fisher), 0.3 mM dNTPs,
0.3 mM of each primer, 16Q solution (Qiagen) and 1 ml cDNA
synthesized with RevertAidM-MuLV reverse transcriptase. Ther-
mocycling was conducted in a Biorad C1000 or S1000 cycler with
initial denaturation at 98uC for 1 min followed by 35 cycles with
denaturation at 98uC for 10 s, annealing at a primer pair specific
temperature for 30 s and elongation at 72uC for 20 s to 2 min. For
full-length PCRs, primers flanking the open reading frame were
chosen. Full-length primers for B. malayi, D. immitis and O.
gutturosa were obtained from genome data [41]. Further details
about primer sequences are available in S1 Table. PCR products
were gel-purified and cloned into the pCR4 TOPO blunt vector
(Invitrogen) and sequenced by GATC Biotech.
Identification of protein motifs in Slo-1 channels
Molecular weight and putative isoelectric points were calculated
with Clone Manager 9 (Scientific and Educational Software).
Localization of transmembrane regions was predicted using
TMPred software [42]. Conserved domains and Prosite motifs
were identified using CD-BLAST [43,44] and InterProScan
[45,46]. Prediction of phosphorylation sites was performed using
NetPhosK 1.0 [47].
Phylogenetic analysis
Slo-1 sequences from the present study were aligned with
homologs available in GenBank or Wormbase, and homologs
from Meloidogyne incognita [48] and S. ratti (obtained from the
Sanger genome project). Deduced protein sequences were aligned
using ClustalX2 [49]. Alignments were analyzed with Prottest
3.0.1 [50] to identify the most appropriate amino acid substitution
model. PhyML 3.0.1 [51,52] was then used to determine tree
topology and branch support as described [53]. In brief, the JTT
model for amino acid substitution [54] with 16 C distributed
substitution rate categories was used. PhyML was set to estimate C
shape parameter and proportion of invariable sites while amino
acid frequencies were set to be based on the substitution model.
Nearest neighbor interchange (NNI) and subtree pruning and
regraftment (SPR) moves were allowed to optimize the tree
topology. Both Bayesian transformation and Shimodaira-Hase-
gawa-like modifications of the approximate likelihood test were
used to calculate branch support. Tree optimization started with
one neighbor-joining and 5 random trees and the tree with the
highest likelihood was finally chosen and visualized in MEGA5
[55].
For analysis of the conserved alternative exon, ProtTest 3.0
identified the same model as for the full-length sequence and
PhyML was executed using identical parameters as for the full-
length sequence.
Characterization of Nematode Slo-1
PLOS Neglected Tropical Diseases | www.plosntds.org 3 December 2014 | Volume 8 | Issue 12 | e3401
Experimental detection of differential splice products
The primers flanking the putative splice site (S1 Table) were
used in a two-step RT-PCR as described above. PCR products
were analyzed on 2.0% agarose gels and with the DNA 1000 kit
on the Bioanalyzer 2100 (Agilent). Gel-purified DNA fragments
were cloned and sequenced. Quantification of fragments was
performed using the Bioanalyzer Expert software.
Trichuris suis transcriptome data
For RNA-seq experiments, total RNAs were extracted from
larvae at day 10 [approximately 50,000 first and second stage larvae
(L1 and L2) from 5 experimentally infected pigs], day 18 [15,000
third stage larvae (L3) from 4 pigs] and day 28 p.i. [3,000 fourth
stage larvae (L4) from 2 pigs], from whole adult male (n= 10), adult
female (n= 10) or from multiple stichosomes (mixed sex; n= 10),
posterior portions of adult females (n= 10), including the eggs, and
of adult males (n= 10) using the TriPure reagent (Roche). Yield and
quality were verified using the 2100 Bioanalyzer (Agilent). For
library production, purification of polyadenylated (polyA+) RNA
from 10 mg total RNA from each sample was carried out using Sera-
mag oligo(dT) beads (Thermo Scientific). Then RNAs were
fragmented to a size of 300–500 bp, reverse-transcribed using
random hexamer primers, end-repaired and adapter-ligated accord-
ing to the manufacturer’s protocol (Illumina). Ligation products of
approximately 400 bp were eluted from agarose gels, PCR-amplified
(15 cycles) as recommended and purified on MinElute columns
(Qiagen). Finally, libraries were subjected to paired-end RNA-seq
using HiSeq 2000 (Illumina) and assessed for quality and adapter
sequences. After sequencing, raw reads were trimmed of Illumina
adapters, filtered for length ($ 40 nt) and low-quality data (reads
containing 4 or more consecutive bases showing a PHRED quality
below 20). Transcripts for each stage and/or body portion as well as
the Illumina RNA-seq data from a mixed-sex adult T. suis
transcriptome generated previously [56] were reconstructed and
quantified by Jex et al. [57] using the Tuxedo suite [58] and a draft
assembly of the T. suis genome [57]. Differential transcription was
assessed using NOISeq [59], with 20% of the evaluated reads for
each library used in 5 iterations to simulate technical replicates (note:
all RNA-seq libraries were constructed from multiple parasites, i.e.,
10 adults or 50,000 larvae retrieved frommultiple host individuals to
compensate for inter-individual biological variation).
Preparation of slo-1 cRNAs
Full-length cDNAs encoding C. elegans Slo-1a and T. muris Slo-
1.1a in pCR4TOPO (Invitrogen) were used. Plasmid DNA was
linearized in 100 ml buffer containing 8 mg plasmid DNA and 100 U
XbaI (for C.elegans SLO-1a) or 100 U BcuI (for T. muris SLO-1.1a)
at 37uC for 2 h. Linearized plasmid DNA was purified via the
GeneJet PCR Purification kit (Thermo Fisher Scientific) and eluted
with 50 ml UltraPure DNase/RNase-free distilled water. Lineariza-
tion of the plasmid DNA was monitored by agarose gel electropho-
resis. DNA concentration was determined using the DNA 12000 kit
and the 2100 Bioanalyzer (Agilent Technologies) according to the
manufacturer’s instructions. For cRNA synthesis from 1 mg linearized
plasmid DNA, the mMessage mMachine T7 transcription kit
(Ambion) was used according to manufacturer’s instructions. To
determine the integrity and concentration of the transcribed cRNA,
the RNA 6000 Nano kit and the 2100 Bioanalyzer (Agilent
Technologies) were used according to the manual.
Microinjection of Xenopus oocytes
Defolliculated Xenopus laevis oocytes were obtained from
EcoCyte Bioscience (Castrop-Rauxel, Germany). After delivery,
single oocytes were transferred into individual cavities of a 48 well
plate containing Barth’s solution (88 mM NaCl, 2 mM KCl,
1 mM MgCl2, 15 mM Tris HCl, 0.5 mM CaCl2, pH 7.4) and
incubated for at least 2 h at 19uC before use. 75 nl of either
200 ng/mL C. elegans SLO-1a cRNA or T. muris SLO-1.1a were
microinjected into each oocyte using the Roboinject (Multi
Channel Systems MCS GmbH). Oocytes injected with 75 nl
water served as negative control. Position of impalement was set to
350 mm, whereas position of injection was set to 400 mm. Oocytes
were incubated at 19uC for 3-4 days post microinjection. Barth’s
solution was replaced daily.
Voltage clamp experiments with Xenopus oocytes
Experiments were carried out using the Roboocyte (Multi
Channel Systems MCS GmbH). In the Roboocyte, oocytes were
perfused with normal frog Ringer solution (NFR: 90 mM NaCl,
2 mM KCl, 2 mM CaCl2, 1 mM MgCl2, 5 mM HEPES, pH 7.4)
for 1 min before electrodes were inserted and membrane potential
was clamped to 270 mV. Experiments were carried out as
summarized in S1 Fig.. In general, initial current-voltage curves
(IVCs) were recorded after another perfusion for 1 min. Currents
were recorded at a frequency of 1000 Hz during clamping the
membrane potential between2120 and +60 mV for 500 ms using
voltage steps of 20 mV (S1B Fig.) and mean currents for each
voltage step were calculated from these 500 individual values.
Between individual steps, the membrane potential was clamped to
270 mV for 3 s. After initial recordings of IVCs, a perfusion with
NFR was performed for 2 min before repeating the recording to
ensure that responses were stable over time (S1A(I) Fig.). Oocytes
showing currents exceeding 250 nA at +60 mV were excluded
from further experiments. To determine the effects of drugs,
oocytes were first incubated with the vehicle (0.1% DMSO,
0.003% Pluronic F-68 (Sigma Aldrich) for 2 min. Vehicle,
emodepside and blockers were always added manually into the
well. IVCs were recorded and oocytes were again perfused for
1 min before incubation with emodepside (1 or 10 mM) and
another recording (S1A(II) Fig.). Since the actual concentration of
emodepside at its target site is completely unknown, 10 mM
emodepside, which is the highest concentration soluble in water
with 0.1% DMSO and 0.003% Pluronic F-68, was compared with
1 mM emodepside to identify any potential concentration depen-
dent effects.
To test whether potential emodepside effects were reversible,
oocytes were perfused for 5 to 10 min with NFR after an IVC
recording in the presence of emodepside (S1A (III), (IV) Fig.).
Effects of the blocker verruculogen (1 mM) were determined both
before and after addition of emodepside (1 mM) to the oocytes
(S1A (V), (VI) Fig.). Currents were recorded using Roboocyte
ClampAmp software 2.2.0.15.
Statistical analysis of electrophysiological data
Mean currents during each voltage step were calculated for
individual oocytes in Roboocyte ClampAmp. To obtain IVCs,
mean currents 6 SEM for all replicate oocytes were plotted
against the voltage used to clamp the membrane potential in
GraphPad Prism 6.00. Mean currents between different groups of
oocytes were compared separately for every step potential applied
using the multiple t-test function in GraphPad Prism . P values
were corrected for multiple comparisons using the Holm-Sidak
method. Certain parts of the IVC were analyzed for different
slopes and for linearity using the linear regression analysis in
GraphPad Prism followed by the Wald-Wolfowitz runs test
implemented in this analysis.
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Results
Comparison of slo-1 cDNAs and encoded proteins
S2 Table summarizes the physico-chemical properties of
predicted nematode Slo-1 subunits compared to homologous
proteins from other nematodes and some orthologs from other
species used as outgroup in further phylogenetic analysis. Only a
single full-length cDNA sequence was identified from clade III
nematodes (B. malayi, O. gutturosa, P. equorum, A. suum and T.
canis), although alternative exons were identified in partial PCR
products. These sequences were not included in the initial analysis
of differential splicing since no information regarding possible
combinations of different exons is currently available for them. For
B. malayi, six different isoforms (BmaSlo-1c-h) are annotated in
Wormbase and isoform BmaSlo-1f was identical to the one
identified in the present study (S2 Fig.). For D. immitis two variants
were identified differing only in a short region encoding amino acids
678 - 692 in DimSlo-1a, which is missing in DimSlo-1b (S2 Fig.).
In the clade I nematode T. muris, two partial genomic sequences
encoding Slo-1 homologs were identified in contigs NODE_
15952_length_5825_cov_10.724463 and NODE_133417_length_
23144_cov_11.427541. Full-length cDNAs of both paralogs were
amplified and cloned. Comparison with Trichinella spiralis
sequences in GenBank revealed that this clade I nematode also
encodes two distinct Slo-1 homologs in its genome. The T. spiralis
Slo-1.1 protein sequence can be found as two partial entries which
cover the whole length under the GenBank accession numbers
XP_003370273.1 and XP_003370274. The T. spiralis Slo-1.2
database entries XP_003370270.1, XP_003370271.1 and XP_
003370272.1 correspond to the T. muris Slo-1.2. In both
trichocephalids, the two paralogs are juxtaposed in the genome in
a tail-to-tail orientation.
Two splice variants encoding full-length T. muris Slo-1.1
channels (Slo-1.1a and Slo-1.1b) were identified. In addition, two
splice variants encoding severely truncated proteins were cloned;
truncation is caused by retention of a partial or entire intron in the
mature RNA leading to premature stop codons (TmuSlo1.1c and
TmuSlo-1.1d in S2 Fig., respectively). Using primers flanking these
introns, a semiquantitative estimate of the frequency of the splice
variants was possible in two independent T. muris isolates. PCR
products were separated on agarose gels (Fig. 1A) and the
Bioanalyzer (Fig. 1B). The latter was used to quantify the amount
of DNA in the peaks (Table 1). In contrast to the initial impression
from agarose gels, where the large PCR products encoding the
truncated versions produced the brightest bands, the Bioanalyzer
clearly shows that the smallest fragment encoding full-length
channels represents the majority of amplicons in terms of
molecules (77 and 84%). To reveal if these truncated channel
versions are present in related species, data from a T. suis
genome/transcriptome project were analyzed for the presence of
different slo-1 splice products. A multi sequence alignment of the
encoded protein sequences is given in fasta format in S3 Fig..
Truncated versions due to retained introns were observed in both
TsuSlo-1.1 and TsuSlo-1.2 in the same region of the channel (i.e.,
the transmembrane helix S4 and the voltage sensor comprised of
S5 and S6), but the introns involved in these events were not at
exactly the same position. Remarkably, alternative exons were
found immediately before the retained introns, with one splice
variant only present among cDNAs encoding full-length channels
(TsuSlo-1.1.4/7) and the alternative variant only in the truncated
versions (TsuSlo-1.1.2/5/10 and 14). In addition, splice variants
encoding even shorter channels than those found in T. muris were
identified (TsuSlo-1.1.1/3/8/12). Quantitative analysis of tran-
scriptome data revealed for Tsuslo.1.1 that the most abundantly
detected splice variant corresponds to the full-length splice variant
Tsuslo-1.1.4 in terms of fragments per kilobase of exons per
million fragments mapped (FKPM), whereas the other full-length
variant Tsuslo1.1-7 was found at much lower abundance (Fig. 2).
The second most abundantly detected splice variant (Tsuslo1.1.10)
Fig. 1. Estimation of splice variant abundances encoding
truncated or full-length versions of Trichuris muris Slo-1.1. A)
Primers flanking the introns retained in the cDNAs encoding the
truncated proteins (TmuSlo-1.1c and TmuSlo-1.1d) were used in RT-PCR
(lanes 1, 2, 5, and 6) and genomic PCR (lanes 4 and 8). Template was
either derived from the Monheim (lanes 1–4) or the Edinburgh Zoo
(lanes 5–8) isolate. Lanes 3 and 7 show no reverse transcription controls.
M, 100 bp ladder. B) Representative samples separated on the
Bioanalyzer. The upper panel shows a genomic PCR product, the
middle panel the control without reverse transcription and the bottom
panel the RT-PCR.
doi:10.1371/journal.pntd.0003401.g001
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encodes a severely truncated protein of similar length as the
truncated T. muris variants detected by RT-PCR (S2 Fig.).
Remarkably, there are very obvious differences in frequency of
splice variants.For example, the frequency of Tsuslo-1.1.10 ranged
between 20% in adults and 35% in L1, with L3 and L4 showing
intermediate frequencies (Fig. 2A). Additional stage specific
splicing is exemplified by the channels encoded by Tsuslo-1.1.2/
5/14 and Tsuslo-1.1.3: While the former encodes a channel very
similar to Tsuslo-1.1.10, but differing in its NH2 terminus, the
latter variant is extremely truncated (S2 Fig.). Notably, the
abundance of Tsuslo-1.1.10 is relatively high among slo-1.1
transcripts during larval development, peaking in the L1/L2 stage
(Fig. 2A). In contrast, transcription of this highly truncated slo-1.1
splice variant was relatively low (statistically significant at a false
discovery rate of 0.1) in most adult libraries, with the major
exception being the stichosome, in which it displayed its highest
abundance. Other minor slo-1.1 isoforms, including some slo-1.1
variants, showed evidence of differential transcription during
development and in adulthood among genders/tissues. However,
because single library replicates were used for each tissue and stage
of T. suis, statistical assessment of the differential transcription
of these minor isoforms is not advisable. We consider these
differences both preliminary and qualitative at this stage. In
contrast to Tsuslo-1.1, little variation in transcription of Tsuslo-1.2
channel variants was observed among developmental stages or
adult tissues/genders, with Tsuslo-1.2.6 (the full length transcript)
being the major isoform (Fig. 2C and D).
Comparison of splice variants in parasitic nematodes with the
15 splice variants described for C. elegans reveals five main regions
where differential splicing occurs (S2 Fig.). The first site is an
alternative exon (i.e., present or not), the absence of which results
in the use of a downstream ATG start codon only in T. suis Slo-
1.1 and 1.2. Insufficient data are available to determine whether
this splicing also occurs in T. muris. The first alternative exon
identified in C. elegans (region 2 in S2 Fig.; also a ‘present or not’
type) was not found in any of the parasitic nematode slo-1 cDNAs.
Splicing region 3 refers to a larger region where differential
splicing occurs in all four Trichuris genes in different positions.
Many but not all of the encoded proteins are severely truncated.
The fourth splicing site (alternative exons) has been conserved
throughout the evolution of Slo-1 channels in nematodes and two
versions are present in T. muris and T. suis Slo-1.1. In all seven
sequences cloned from ascarids and filariae, the corresponding
region shows higher similarity to C. elegans Slo-1a. However,
alternative sequences were identified in the genomes of A. suum,
O. volvulus and B. malayi (BmaSlo-1h in S2 Fig. and S2 Table).
Alternative splicing occurs in exactly the same position in
arthropods and vertebrates. This alternative exon immediately
follows two highly conserved phosphorylation sites. Remarkably,
two of the predicted B. malayi splice variants contain a partial
duplication (approximately two thirds of the whole exon BmaSlo-
1c/d). Splicing site four in C. elegans (position 5 in S2 Fig.;
‘present or not’ type with two different 5’ splice sites) has no
equivalent in any of the Trichuris sequences, but there is
alternative splicing in the same area in B. malayi and D. immitis.
The sixth splice region is found in C. elegans but is apparently not
present in clade III and clade I parasitic nematodes.
Phylogenetic analysis of Slo-1 channels
A maximum-likelihood approach was used to calculate a
phylogenetic tree from the SLO-1 amino acid sequences (Fig. 3A).
As outgroup, three sequences from vertebrates, one from a mollusc
and five from arthropods were included in the analysis. Slo-1
channels of nematodes and arthropods formed a monophyletic
group in accordance with their phylogenetic position within the
Ecdysozoa. In general, most of the tree topology is consistent with
current views on nematode evolution. However, the position of the
Slo-1 proteins from the clade IV nematodes M. incognita and S.
ratti is basal to a group containing all clade III and clade V
sequences, but the support values for this position are rather low in
both versions of the approximate likelihood test (Fig. 3A). The
additional paralog Slo-1.2 present in clade I parasitic nematodes is
placed as a sister operational taxonomic unit (OTU) to the Slo-1.1
paralog in this clade. This suggests that duplication of the slo-1
gene occurred after the trichocephalids diverged from the other
groups and is not an ancestral feature of nematode genomes.
To prove that differential splice variants were conserved
throughout nematode evolution at the C. elegans alternative splice
site four, only the amino acid sequences of this exon were aligned
and subjected to phylogenetic analysis. For this purpose,
alternative exons identified in the genomes of A. suum and O.
volvulus were included. The partial duplication of this exon in
BmaSlo-1c/d was also included as a separate OTU [BmaSlo-1c
(part. dupl.) in S2 Fig]. Results are depicted in Fig. 3B. Due to the
small size of the sequence, statistical support for individual nodes is
lower than for full-length sequences. However, there is clearly a
nematode-specific group with high similarity to the sequence in C.
elegans Slo-1a, although the exon sequences in the trichocephalid
species strongly diverge from those in clade III and V nematodes.
The second group contains exon sequences from both nematodes
and arthropods, including both alternative exons encoded in the
D. melanogaster genome. Diversity within this group is much
higher and deep divergence patterns could not be resolved.
Therefore, the group consists of three major lineages, i.e. (i)
Trichuris Slo-1.1b-like and arthropod sequences which might
therefore be considered to be ‘‘ancestral’’, (ii) the exon encoded in
Slo-1.2 genes, (iii) the sequences derived from clade III and V
nematodes.
Table 1. Relative abundance of cDNA amplicons encoding full-length or truncated Trichuris muris Slo-1 channels.
T. muris isolate
Monheim Edinburgh Zoo
-RT control no amplicon no amplicon
Genomic PCR 353 bp 100%60% 353 bp 100%60%
RT-PCR 67 bp 77.660.6% 67 bp 83.8%60.4%
180 bp 7.8%60.4% 180 bp 4.5%61.7%
353 bp 12.7%60.6% 353 bp 11.662.0%
doi:10.1371/journal.pntd.0003401.t001
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Voltage clamp experiments
Voltage-dependent currents were measured in water-injected
oocytes (Fig. 4A). An inward-directed current was detected at very
low negative step potentials (-120 mV to -80 mV) whereas an
approximately linear increase of outward currents was detected
between -60 mV and +60 mV (Fig. 4A and 5A). In water as well
as in CelSlo-1a or TmuSlo-1.1a injected oocytes no significant
differences were observed between repeatedly recorded IVCs,
indicating that the oocytes were in good physiological condition.
Currents detected in water-injected oocytes were not significantly
Fig. 2. Frequencies of splice variants in terms of fragments per kilobase of exons per million fragments mapped (FKPM). Libraries
were compared according to developmental stage (A) and (C) as well as different sexes or tissues (B and D). Splice variants were grouped according
to the encoded protein, i.e. frequencies of splice variants encoding the same protein and differing in sequence downstream of the stop codon were
added together. A) and B) show expression patterns of Tsuslo-1.1 and C) and D) indicate patterns for Tsuslo-1.2 splice variants. L1, L2, L3, L4, first,
second, third, fourth stage larvae; Mal., males, Mal. post., posterior part of males; Fem., Females; Fem. post., posterior part of females; Stich.,
stichosome.
doi:10.1371/journal.pntd.0003401.g002
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influenced by the vehicle (0.1% DMSO +0.003% Pluronic F-68)
or by 10 mM emodepside (Fig. 5A). In the absence of emodepside,
basal IVCs between water and CelSlo-1a injected oocytes were
very similar. However, there was a small but significant higher
current at +20 mV in CelSlo-1a injected oocytes (Fig. 5B), which
corresponds to the voltage of approximately 0 to +20 mV needed
to open CelSlo-1a at a low Ca2+ concentration of 10 mM [60].
This difference was also observed in the presence of the vehicle
and there was no significant difference between basal IVCs and
IVCs in the presence of the vehicle (Fig. 5B). Interestingly,
currents did not increase further when step potentials above +
20 mV were applied (Fig. 5B) and no differences to water-injected
oocytes were observed at +40 and +60 mV (Fig. 5B). In addition,
slightly larger negative and slightly higher positive currents were
apparently observable at very low (-120 to 100 mV) and at slightly
negative (-40 to -20 mV) voltages, respectively. Since the direct
comparison of currents for individual voltages did not indicate
significant differences, the range between -120 and -20 mV was
subjected to linear regression. The runs test implemented in
GraphPad Prism did not find any significant deviation from
linearity for any of the data sets using the voltage range as shown
in Fig. 5B. Remarkably, slopes for CelSlo-1a injected oocytes were
significantly higher (p,0.0001) than for water injected oocytes, no
matter if DMSO was present in the medium of the CelSo-1a
injected oocytes or not. Presence of the vehicle did not change the
slope significantly (p = 0.89). The increased slopes demonstrate a
voltage-independent increase in membrane conductance due to
injection of Celslo-1a cRNA.
No increase in currents at +20 mV was detected in oocytes
injected with TmuSlo-1.1a cRNA (S4 Fig.). In fact, currents
measured in TmuSlo-1.1a-injected oocytes were significantly lower
than in water-injected oocytes at 0 mV and +20 mV step
potential. At high step potentials (+40 - +60 mV), these IVCs
deviated from linearity, suggesting a nonphysiological response of
the oocytes. Linear regression of data between -120 and -20 mV
again showed no deviation from linearity. In contrast to the data
obtained after injection of CelSlo-1a, the slope was not increased
but even decreased by TmuSlo-1a. Injection of more TmuSlo-1.1a
cRNA (up to concentrations of 750 ng/mL) and longer incubation
between injection and electrophysiological measurements (up to
six days) did not improve the results. In contrast, higher cRNA
amounts only increased deviation from linearity while longer
incubation times had no detectable effects. In an attempt to
increase the difference for CelSlo-1a or TmuSlo-1.1a, oocytes were
preincubated in 2 mg/ml of the Ca2+ ionophore A23187 (Sigma
Aldrich) in Ca2+ free Barth’s medium for 15 min followed by three
washes with normal Barth’s medium. However, this pretreatment
did not increase the response but caused severe leak currents.
In the absence of a stimulus increasing [Ca2+]i, addition of
emodepside to CelSlo-1a-injected oocytes resulted in dramatically
increased currents (Fig. 4C) with significantly stronger effects at
10 mM than 1 mM emodepside (Fig. 5C). Differences were signif-
icant at all step potentials except for +60 mV at both emodepside
concentrations. IVCs obtained in the presence of emodepside are
characterized by two very remarkable features. Firstly, currents
increased even at step potentials far below the expected opening
potential of Slo-1 channels, suggesting that channel opening can
occur independently of membrane potential. Secondly, currents
peaked at 0 mV and significantly decreased at higher step
potentials, resulting in bell shaped IVCs (Fig. 5C). At the highest
step potentials used (+60 mV), differences between vehicle controls
and emodepside-treated oocytes were no longer significant.
Wash out of 1 mm emodepside for 5 min and wash out of
10 mM emodepside for 10 min had no effect on IVCs. Even
perfusion for 25 min did not reduce the emodepside effects (n = 3).
Effects of verruculogen, a specific blocker of mammalian K+
channels with high conductance [61], revealed that the order of
addition strongly influenced the outcome. Preincubation of
oocytes with verruculogen alone had no effects on IVCs; neither
the slight increase in currents at +20 mV observed in CelSlo-1a-
injected oocytes nor the increased slope in CelSlo-1 injected
oocytes were blocked (compare Fig. 5B and 5E). However,
addition of verruculogen before emodepside completely prevented
emodepside effects on IVCs (Fig. 5E). This also shows that
verruculogen effects on BK channels are not limited to mamma-
lian channels. In contrast, when verruculogen was added to
oocytes in the presence of emodepside, no decrease in emodep-
side-induced currents was detected (Fig. 5F).
Discussion
The mode of action of cyclooctadepsipeptides has long been a
matter of debate, with ionotropic GABAA receptors [39,62], the
latrophilin receptor Lat-1 [25,63] and the Slo-1 channel [19-21]
consecutively deemed to be the most likely receptors. Although
Slo-1 is generally considered to be the most important target based
on experiments using forward and reverse genetics, there has been
no direct evidence for emodepside activation of the Slo-1 channel.
Responses of excitable muscle/neuronal cells to emodepside
develop much slower [21,64] than usually observed during direct
gating of ionotropic receptors, which meant that indirect effects of
emodepside on Slo-1 could never be completely excluded [64].
Using an oocyte expression system eliminating all nematode-
Fig. 3. Phylogenetic analysis of nematode Slo-1 channels. A) Phylogram obtained by maximum likelihood analysis from full-length Slo-1
channels. Slo-1 protein sequences from the nematode species Caenorhabditis elegans (Cel), Caenorhabditis briggsae (Cbr), Caenorhabditis remanei
(Cre), Pristionchus pacificus (Pca), Haemonchus contortus (Hco), Cooperia oncophora (Con), Ancylostoma caninum (Acan), Onchocerca gutturosa (Ogu),
Brugia malayi (Bma), Dirofilaria immitis (Dim), Toxocara canis (Tca), Parascaris equorum (Peq), Ascaris suum (Asu), Meloidogyne incognita (Min),
Strongyloides ratti (Sra), Trichuris muris (Tmu) and Trichuris suis (Tsu) were aligned together with orthologs from Drosophila melanogaster (Dme),
Anopheles gambiae (Aga), Pediculus humanus corporis (Phu), Daphnia pulex (Dpu), Aplysia callifornica (Acal), Gallus gallus (Gal), Bos taurus (Bta) and
Homo sapiens (Hsa), which were used as outgroup, using ClustalX2. For B. malayi only the experimentally identified splice variant Slo-1f and for C.
elegans only the variants Slo-1a-c were included. The JTT model of amino acid substitutions was used and PhyML was set to optimize the number of
invariable sites while amino acid frequencies were based on the model. The number of C distributed substitution rate categories was set to 16 and
PhyML optimized the C shape parameter. Support for individual nodes was calculated using the Shimodaira-Hasegawa modification and a Bayesian
transformation of the approximate likelihood ratio test and results are shown close to the nodes before and after the slash, respectively. For those
cases where support values were not shown next to the node they are shown on the right and refer to the most terminal node on the same vertical
position. The scale bar represents 0.2 substitutions per site. C, Crustacea; G, Gastropoda; Vert, Vertebrata; Arthropod, Arthropoda, M, Mollusca; L,
Lophotrophora; Deut, Deuerostomia. B) Phylogenetic tree calculated on an alignment of the conserved alternative exons from all Ecdysozoa included
in the tree in A). In addition, four alternative exons identified in BmaSlo-1h and in the genome sequences of Onchocerca volvulus (OvoSlo-1 and
OvoSlo-1 alt. exon) and A. suum (AsuSlo-1 alt. exon) were included. Parameters were identical to those used to calculate the tree from full-length
sequences.
doi:10.1371/journal.pntd.0003401.g003
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related confounding factors, the present study for the first time
demonstrates direct effects of emodepside on Slo-1 channels. In the
presence of emodepside, highly increased currents were observed
without depolarization up to a threshold of 0 mV and without any
additional stimuli to artificially increase [Ca2+]i levels. These novel
findings confirm that Slo-1 is a direct target of emodepside.
The X. laevis expression system has been widely used to
characterize the function of nematode ion channels and in
particular receptors for neurotransmitters [65-67]. It has several
advantages, including robustness, simultaneous expression of
proteins (e.g., auxiliary proteins or multiple subunits) [66], and
large cells which allow easy application of the two electrode
Fig. 4. Currents observed in voltage-clamp experiments. Representative currents determined in oocytes injected with water (A), Celslo-1a
cRNA in the absence of emodepside (B) and Celslo-1a cRNA in the presence of 10 mM emodepside (C).
doi:10.1371/journal.pntd.0003401.g004
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Fig. 5. Determination of emodepside effects on current voltage curves in Xenopus laevis oocytes injected with Celslo-1a cRNA. A)
Current voltage curves (IVCs) (means 6 SEM) were recorded in water-injected oocytes without addition of drugs (basal), after addition of the vehicle
(0.1% DMSO, 0.003% Pluronic F-68) and after addition of 10 mM emodepside (emo) (n = 10). B) Currents obtained from oocytes injected with water
(n = 10) or Celslo-1a cRNA in the absence of any drug (basal, n = 8) or in the presence of vehicle (0.1% DMSO, 0.003% Pluronic F-68, n = 8). The asterisk
highlights a significant difference of both curves obtained from Celslo-1a cRNA injected groups of oocytes to the water-injected oocytes. C) Currents
were recorded in Celslo-1a injected oocytes at the presence of vehicle (0.1% DMSO, 0.003% Pluronic F-68), or emodepside (1 mM or 10 mM emo)
(n = 10). For 10 mM emodepside the upper asterisks symbolize the comparison to 1 mM emodepside and the lower the comparison to the vehicle
control. The asterisks at the 1 mM emodepside curve indicate significant differences to the control. D) Oocytes injected with Celslo-1a were incubated
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voltage clamp technique (TEVC) [68]. However, there is also a
drawback of using oocytes when working with Ca2+ responsive
channels such as Slo-1. In particular, the cell is so large that it is
not possible to increase the [Ca2+]i to levels required for
physiological activation of BK channels. Inside-out patch clamp
recording would be required to perform this type of experiment
[60]. Therefore, activation of the Slo-1 channel by simultaneously
increasing the [Ca2+]i and depolarization of the cells was not
possible in this configuration. Attempts to increase [Ca2+]i by
preincubation of oocytes with the Ca2+ ionophore A23187 were
not successful and resulted in oocytes looking very unhealthy and
exhibiting large leak currents. Effects of emodepside on K+
currents in A. suum muscle flaps have been shown to be dependent
extracellular Ca2+ [64]. Currently, data do not rule out completely
that this is also the case for the experimental system used here since
emodepside might itself increases [Ca2+]i directly in X. laevis
oocytes although it had no effect in mammalian HEK293 cells [25].
A minor activity of CelSlo-1a channels was already observed in
the absence of emodepside, i.e. the slope of the IVC was increased
in oocytes injected with Celslo-1a cRNA. This increase in
membrane conductance can probably be explained by a minor
number of CelSlo-1a channels that are in an open state even in the
absence of high [Ca2+]i and membrane depolarization. However,
strong activity of the CelSlo-1a channel was only observed in the
presence of emodepside, and currents mediated by TmuSlo-1.1a
could not be observed at all. In the absence of any other known
agonist of nematode Slo-1 channels and without the ability to
prove functional expression of TmuSlo-1.1a by determining
currents evoked by increased [Ca2+]i and depolarization, the
failure to detect emodepside effects cannot be interpreted as
emodepside unresponsiveness. In fact, currents in TmuSlo-1.1a-
injected oocytes were lower than those observed in water-injected
oocytes, suggesting that some non-physiological changes have
occurred in the cells. This is supported by the fact that the IVCs in
the absence of emodepside significantly deviated from linearity at
high voltages, unlike currents observed in water-injected oocytes.
Moreover, the slope of the IVC between -120 and -20 mV was
lower than in the water-injected control oocytes. In marked
contrast, CelSlo-1a increased the slope and therefore membrane
conductance suggesting expression of functional CelSlo-1a but not
TmuSlo-1.1a channels. Since T. muris is fully susceptible to
emodepside [37,69,70], it is unlikely that Slo-1 from this parasite
should not respond to this drug. However, due to the presence of
two slo-1 paralogs in the T. muris genome, it cannot be ruled out
that only TmuSlo-1.2 is emodepside responsive. Other possibilities
are that only certain T. muris Slo-1.1 splice variants respond to
emodepside or that emodepside acts on T. muris only via the Lat-1
pathway. Optimized expression systems will be needed to
distinguish between these possibilities in future experiments. For
example, codon optimization might improve expression levels.
Vectors that are particularly adapted for protein expression in X.
laevis oocytes are available [71] but usage of this system resulted in
extremely deteriorated oocyte morphology and oocyte rupture
presumably due to toxicity of high levels of CelSlo-1a. Finally,
other expression systems, such as insect or mammalian cells,
should be considered for TmuSlo-1.1a.
In the absence of emodepside, a highly reproducible increase in
current was observed at +20 mV step potential, which corresponds
to the opening potential reported for C. elegans Slo-1a at low Ca2+
concentrations [60]. This small current may represent a minor
depolarization-dependent activation of a few channels even in the
absence of Ca2+ signaling. However, it remains unclear why this
was not observed at more positive step potentials. Moreover,
increased currents at +20 mV and increased slope of the IVC were
also observed in the presence of the Slo-1 channel blocker
verruculogen regardless if addition of verruculogen was followed
by exposure to emodepside. Preincubation with verruculogen
completely abolished the effects of emodepside. In contrast,
verruculogen had no significant effect when emodepside was
applied first. This suggests that both drugs bind very tightly to
CelSlo-1a and cannot displace each other once they have bound.
High-affinity binding of emodepside to its target is also suggested
by the fact that prolonged perfusion of the oocytes after removal of
emodepside did not reverse channel opening. Very similar
observations have been reported for effects of emodepside on A.
suum muscle flaps [64]. Together with the slow onset of
emodepside effects [64], the fact that the drug effects were not
reversible might suggest that emodepside does not bind to the
extracellular domain of Slo-1, but instead binds to an intracellular
domain or to the transmembrane helices. The latter possibility is in
agreement with its highly lipophilic nature.
Emodepside opened the CelSlo-1a channel at virtually all step
potentials, since currents were much higher than in the controls
except at +60 mV. Unexpectedly however, the response did not
increase linearly with step potential, but peaked at 0 mV, which is
unusually low. The decreasing current at higher potentials and the
lack of emodepside effects at +60 mV might be explained due to
inhibition of Slo-1 channels by high intracellular concentrations of
Ca2+ or Mg2+ as reported for mammalian BK channels (see [72]
and references therein). Although [Ca2+]i can be expected to be
fairly low since there was no increased current in the absence of
CelSlo-1, the concentration of Mg2+ in X. laevis oocytes has been
reported to be approximately 0.7 mM [73]. Whether this is also
the case in the present study could not be resolved using the
current voltage-clamp set up, but requires patch-clamp studies in
which the concentration of these cations can be tightly controlled.
Indeed, decreased currents at high step potentials in response to
emodepside have not been observed for expression of C. elegans
Slo-1 in HEK293 cells [74].
Despite their very similar morphology, genetic diversity of
nematodes is known to be huge [75]. Although Slo-1 is a highly
conserved channel in metazoans, it was not clear whether
emodepside exerts its nematicidal effects through the same
mechanisms in all nematode clades. The present study now offers
the tools to compare the physiology of Slo-1 channels from
different parasitic nematode lineages using optimized expression
systems. The various slo-1 splice variants identified in parasitic
nematodes show that evolution has occurred at highly conserved
alternative splice sites (splice region 4 with alternative exons
present in nematodes, arthropods and vertebrates at the same
position) along with evolution of nematode or clade-specific splice
variants. Effects of these variations and of possible heteromeriza-
with 1 mM (n=6) or 10 mM (n=7) emodepside (emo) before recording the IVC curves. Then, oocytes were perfused with normal frog ringer for 5 or
10 min, respectively, before a second IVC was recorded from the same oocytes (n = 7). E) Oocytes were preincubated in the absence of drugs (basal)
or with 1 mM verruculogen (verruc) before IVCs were recorded. Then, oocytes were perfused for 2 min before 1 mM emodepside (emo) was added
(n = 8). F) Oocytes injected with water (n = 10) or with Celslo-1 cRNA (n= 6) were incubated in the absence of drugs (basal) or with 1 mM emodepside
before IVCs were recorded. After perfusion with normal frog ringer for 2 min, verruculogen (verruc) was added for 2 min followed by recording of
IVCs.*, p,0.05; **, p,0.01; ***, p,0.001.
doi:10.1371/journal.pntd.0003401.g005
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tion of different subunits on voltage and Ca2+ sensitivity can now
be evaluated in patch-clamp experiments.
That B. malayi and B. pahangi are rather unresponsive to
emodepside in vivo and in vitro [76–78] cannot be easily
explained by the primary structure of BmaSlo-1, which is virtually
identical to that of other filariae. Whether this difference in
susceptibility is due to target site related differences (e.g. different
splice variants or combination of subunits) or due to other (not Slo-
1 related) mechanisms protecting Brugia from emodepside effects
could be answered by comparing electrophysiological properties of
different splice variants between filarial species. In general,
differences in emodepside responsiveness between Slo-1 channels
from different species could also be used to map the emodepside
binding region. Expression of hybrid channels encoded partially
from a susceptible nematode and partially from a resistant species
such as an arthropod followed by determination of emodepside
responsiveness in electrophysiological experiments would allow to
scan the sequence for those regions in the primary structure
required for opening by emodepside.
The high number of splice variants encoding severely truncated
Slo-1 proteins in both Trichuris species should be further
analyzed. Truncated versions of CelSlo-1 with stop codons
between the S4 membrane helix and the end of the first RCK
domain (regulator of conduction of potassium) have been shown to
be highly resistant to emodepside [19], and a truncated version
containing only the NH2 terminal part of a mouse Slo-1 ortholog
from the start codon to the S6 transmembrane region forms a
functional channel [79]. Therefore, a functional role of some of
the truncated versions cannot be excluded, especially in light of the
relatively high number of variants and the fact that expression
levels also appear to be high in both Trichuris species. Truncated
versions of the acetylcholine receptor subunits Unc-63 and Acr-8
have been implicated in resistance to levamisole [80] and
truncated Slo-1 subunits might have dominant negative effects if
they are able to heteromerize with full-length subunits but prevent
the formation of a fully functional channel. That truncated
channels are expressed in variants of both TsuSlo.1.1 and TsuSlo-
1.2, and are apparently more abundant at least in some
developmental stages and worm tissues than others suggests that
these variants might have a physiological function, perhaps in
modulating the activity of full-length gene products. The fact that
temporal as well as spatial variation of splicing is de facto limited to
TsuSlo-1.1 suggests that this splice variant is under less stringent
evolutionary pressure than TsuSlo-1.2. A more detailed spatio-
temporal picture of the expression pattern of the splice variants
would help define their physiological roles.
In conclusion, these data show that the Slo-1 channel of C.
elegans is a direct target of emodepside and that the channel is
present in all important groups of parasitic nematodes of
vertebrates. Sequence diversity of Slo-1 channels among these
groups and within species involves several alternative splice
variants and gene duplications. Interactions of subunit isoforms
and effects on channel physiology and drug susceptibility are
important aspects for more research on nematode neurobiology
and parasitology.
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